Company
Eyevensys
Developing life-changing solutions for patients with severe eye diseases leading to blindness.
Also known as PulseSight Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- PulseSight Therapeutics
Claim, correct or request removal
Record updated 28 September 2026
About
PulseSight Therapeutics is a clinical-stage biotech company developing disruptive, non-viral gene therapies dedicated to ophthalmology, with a current focus on age-related macular degeneration (AMD) including late-stage dry AMD/Geographic atrophy (GA) and wet AMD.
Funding snapshot
- Latest round
- Series A2025-02-13
Funding rounds
- Series A
- 2025-02-13
Products
- Other
- PST-611
- Other
- PST-809
Loading relationship preview